Aspiriant LLC’s iShares MSCI USA Value Factor ETF VLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,810
Closed -$313K 212
2019
Q3
$313K Hold
3,810
0.03% 175
2019
Q2
$309K Hold
3,810
0.03% 176
2019
Q1
$304K Buy
+3,810
New +$302K 0.02% 181

Other funds holding VLUE

Aspiriant LLC's VLUE Position: Q4 2019 in Review

Aspiriant LLC sold out of iShares MSCI USA Value Factor ETF (VLUE) in Q4 2019, closing a stake of 3,810 shares — an estimated $313K sold.

Aspiriant LLC first reported a position in VLUE in Q1 2019 and held it in 3 quarters. The position peaked at $313K in Q3 2019. 220 funds tracked by Wall St. Rank hold VLUE as of Q4 2019.

  • Aspiriant LLC reported no remaining iShares MSCI USA Value Factor ETF position as of Q4 2019 after selling out during the quarter.
  • Aspiriant LLC sold 3,810 iShares MSCI USA Value Factor ETF shares in Q4 2019, an estimated $313K.
  • Aspiriant LLC first reported a position in iShares MSCI USA Value Factor ETF in Q1 2019 and held it in 3 quarters.
  • Aspiriant LLC's iShares MSCI USA Value Factor ETF position peaked at $313K in Q3 2019.
  • 220 funds tracked by Wall St. Rank held iShares MSCI USA Value Factor ETF as of Q4 2019.

Based on Aspiriant LLC's 13F filing for Q4 2019, filed 27 Jan 2020.